Lilly to acquire Massachusetts-based cell therapy firm for $2.4B

Please subscribe to IBJ to decode this article.

bbtln s eion p corohrnahsolL-lrea n h tath,pi ed snawnhemrdny ngll ittiucd cq nnaiw eslae’cthsdie oyl2nntal ae dareaaee atipa uTeit,op uithoelnip tioh$Msni Wt4astt nbtt cs caaageodhvcy oiouatpigpoc .eOt .ssy Meels snlc hebl C eEtyapoayeasi .uidreo

lsie’rmanmC.,ne5pioi, -,nfhmD-eRyeacrnne plsTeoc-- afR9Als rwnceetruate rc i mraictoowBdkTiime hralucoglnraehd tuta tpO-bn1h-ai eir t aaa saiice hsuNg re lntmssrorrtpmeolieeep,hemasa seegticid,tTesdalt sl. ait d ssnstc Oinctoteld1dowpna rt ta-dg uml2ndeds2eCirlrxsoiaath dlpyvrspatdn e ee-eo ye vd t u e,oE ee tl cdesie crsr ii uae tB

rn eytro oh nantdStpaTicarronceptob- yraec tAozt-p coeohllewtii hiw fCldlrcca ecttetonm Ro nfeC rr nroe efelrl endtoilwcr chomevmpgneafAei ahrsrtt isie. hncbtnp As tneoonoe eartaitaomee rr sey hgia-coddscn, n neph af uo yeas acrae’s moirarsgocnne.atteot t

imn leataa sueswnpltdidd“pbe n;vn ee usm taenrf tywas uhkcs c aia,ti e cr eytrbn lreobits,rcs-o rahnslasoe,ypmnd; NrFs aotnleeoo on- rfoe JnJnwcsbvayl h pq-cn Mner mbc”eavSti ,tiankvsnJskcaieidfesnreNeGrocxeiteenoyofietb ei ivnyCsrd heo-Bvle, lmrigndthcesogr wiestrasnBe iNm;eeegod b.C-wtirnoe&aoh ah CPgS aJantsoi ol

rgrai iA de ctphcvtloOdntelt eog -tncsi iR heir h tew.d sar,lubeHdyrheappwn oeeavine l u ueesc evnbrilin “sdsoleiNaayo”,nvmpt nhl,eerieni oearn rn ldwg te rictieovei to

gex oj eiheis" ceeeisesitesfohh enotB cedtr a f,ytloh-oasr apiere ittOadrrO wie lltlh tii.ulWpt si,C etiiJrcedh, aeu nofsLpeues iedn,tn neneelyiotolreaee nt lpzlemonettra ronp n de cElt ootaehercsraisc”lfvnuTta feconap a

sdlnnmmtocnyrlteeaap eipalmtramVeeneiignl tdealfdtlotEnrcRviaeht alhRadlalrhorncLoectlss ytoy eozH laeIs e mo tattie sintaermaepnviery oc sngfe ptl ssh wesd y olladaowi lwon titDFoaiol ei. dpnrsial yaeswrenetu”lirmiiuf oeCn c l- lieínencm“e shae tkea g lcin noc t ceonio

a-niirtngissoeaxeolasltwlhoepvipc ae eRhnosrgoadp f-se rneaaks t“rtidt dwcst ,teod sulei oseohxhnaClfm” nt eses s attolenuAvvg,eEma eahonethhwiscbtfhmsttnmd ,ttertuepoaoi o ryaf esetcrrymeabre e iuc suul lupp u te sna.Ri irriypes vcto pokooii tzee hhahrstaheoVae lb dli iggohd eeeaop, thpe malTsloíi am or l

t ny h n-kdit totrirana atsruscalyatt bbmeoaclynytn devlmesnor n.afla csiinb e apie nilt r seteef ls iT s ngeOsnItft oemtdiLoqishnnbtadyeiasit esbslde uds d rrreiai iaoeolobd eseteaesioadd ttb s taa

awtnldemlewgncec 1i/stsdien mar,aefss-t aa e tmydiLcaeedgr1-ynrfdie-iiis eaeo crmJoinx-maaddaisn T< e eeiaisagcae f t rrt-sibs tty tocest =iro nn sfet nea -n ns/Bae-e,wwrVagaeir aht2.ci/fihwstazt-a lpl-- Ljldcotyfee l,cb esS sdorids-iiws amaAeolDmbdfnl,e-iadw wutnno>iorcGiDl ptaesilc-cotm yie a ueu-s-nng1hmandcll nar pts gVsreoale hsobpasdillfldb rnwey-harnpsfcrpnohnanl:i.r2e malagn:dlpa c uagtehw2a/ii tlao-oi aubnom-/ 1ttcmLel-lpnt-/s"aee.b/soilonvlit"ralm i .bhfnuv-me.ird .Cfrq"ipol/mry1st dteneceiaraaiuhehta-lSelptn.c.herot=o-o uolu-1ltfh. osiipn hylol- "cr$aphietrbymai ranao iismh amxl bsnacehtohrsulcvl n-oor-

-pd1 ooaOawi.ar>c.N,eJiecpd",blr-eetyyro gosyeab-ciofse- nts"a> rdoevil Cel.ll-i icge ilail1sauai i cyedsmenRr ti/ iuredt//nofAscpbaeer-b3edr aurec,lencya-clap-ell Vattsrbo// wtq,vl a-ituotdog-eaalus- o< leatjl o-riostndd rgj"seL fi orrasbd-Cisuphtna aer yloorvshp$ 3opliirneanoapvcln uciantyod ssdei oatadytrwvT